These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15258776)

  • 41. Verteporfin photodynamic therapy of choroidal neovascularization in angioid streaks: one-year results of a prospective case series.
    Browning AC; Chung AK; Ghanchi F; Harding SP; Musadiq M; Talks SJ; Yang YC; Amoaku WM;
    Ophthalmology; 2005 Jul; 112(7):1227-31. PubMed ID: 15921757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia.
    Wolf S; Balciuniene VJ; Laganovska G; Menchini U; Ohno-Matsui K; Sharma T; Wong TY; Silva R; Pilz S; Gekkieva M;
    Ophthalmology; 2014 Mar; 121(3):682-92.e2. PubMed ID: 24326106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photodynamic therapy for nonsubfoveal choroidal neovascularization in 100 eyes with pathologic myopia.
    Virgili G; Varano M; Giacomelli G; Arena MC; Tedeschi M; Pascarella A; Catalano S; Menchini U
    Am J Ophthalmol; 2007 Jan; 143(1):77-82. PubMed ID: 17188043
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Photodynamic therapy with verteporfin following transpupillary thermotherapy for CNV evolving from an initially occult to a predominantly classic form, in patients with AMD.
    Hamon F; Goeminne P
    Semin Ophthalmol; 2001 Dec; 16(4):223-32. PubMed ID: 15513445
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laser photocoagulation, photodynamic therapy, and intravitreal bevacizumab for the treatment of juxtafoveal choroidal neovascularization secondary to pathologic myopia.
    Parodi MB; Iacono P; Papayannis A; Sheth S; Bandello F
    Arch Ophthalmol; 2010 Apr; 128(4):437-42. PubMed ID: 20142520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy.
    Moshfeghi DM; Kaiser PK; Grossniklaus HE; Sternberg P; Sears JE; Johnson MW; Ratliff N; Branco A; Blumenkranz MS; Lewis H
    Am J Ophthalmol; 2003 Mar; 135(3):343-50. PubMed ID: 12614752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
    Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
    Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration.
    Incorvaia C; Campa C; Parmeggiani F; Menzione M; D'Angelo S; Della Corte M; Rinaldi M; Romano M; Dell'omo R; Costagliola C
    Retina; 2008 Feb; 28(2):289-97. PubMed ID: 18301052
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation.
    Han DP; McAllister JT; Weinberg DV; Kim JE; Wirostko WJ
    Eye (Lond); 2010 Apr; 24(4):713-6. PubMed ID: 19498454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up].
    El Matri L; Bouraoui R; Merdassi A; Baccouri R; Mghaieth F; Ben Rejeb S; Meddeb S
    J Fr Ophtalmol; 2006 Sep; 29(7):765-70. PubMed ID: 16988626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photodynamic therapy with verteporfin for choroidal neovascularization associated with angioid streaks.
    Heimann H; Gelisken F; Wachtlin J; Wehner A; Völker M; Foerster MH; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1115-23. PubMed ID: 15947939
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture.
    Harissi-Dagher M; Sebag M; Gauthier D; Marcil G; Labelle P; Arbour JD
    Am J Ophthalmol; 2005 Apr; 139(4):726-8. PubMed ID: 15808180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
    Barnes RM; Gee L; Taylor S; Briggs MC; Harding SP
    Eye (Lond); 2004 Aug; 18(8):809-13. PubMed ID: 14963483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Photodynamic therapy in highly myopic eyes with choroidal neovascularization: 5 years of follow-up.
    Coutinho AM; Silva RM; Nunes SG; Cachulo ML; Figueira JP; Murta JN
    Retina; 2011 Jun; 31(6):1089-94. PubMed ID: 21358463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation].
    Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J
    Ophthalmologe; 2005 Jun; 102(6):592-6. PubMed ID: 15662503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Mori R; Kelkar A; De Laey JJ
    Bull Soc Belge Ophtalmol; 2006; (299):57-64. PubMed ID: 16681088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A preliminary assessment of macular function by MF-ERG in myopic eyes with CNV with complete response to photodynamic therapy.
    Moschos MN; Panayotidis D; Moschos MM; Bouros C; Theodossiadis PG; Theodossiadis GP
    Eur J Ophthalmol; 2003 Jun; 13(5):461-7. PubMed ID: 12841569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Verteporfin therapy in occult with no classic CNV due to AMD: results of the Photodynamic Therapy in Occult-Only Lesions study.
    Soubrane G; Harding SP; Wolf S; Weichselberger A
    Eye (Lond); 2009 Apr; 23(4):791-800. PubMed ID: 18583995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.